Understanding the Relationship between Polycystic Ovarian Syndrome (PCOS) and Dyslipidemia

References (51)

1. 1 Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome (PCOS) [DOI]
2. 2 Polycystic ovary syndrome: a complex condition with psychological, reproductive and metabolic manifestations that impacts on health across the lifespan [DOI]
3. 3 Impaired glucose tolerance, type 2 diabetes and metabolic syndrome in polycystic ovary syndrome: a systematic review and meta-analysis [DOI]
4. 4 The physiology and clinical utility of anti-Müllerian hormone in women [DOI]
5. 5 Scientific Statement on the Diagnostic Criteria, Epidemiology, Pathophysiology, and Molecular Genetics of Polycystic Ovary Syndrome [DOI]
6. 6 Assessment of Cardiovascular Risk and Prevention of Cardiovascular Disease in Women with the Polycystic Ovary Syndrome: A Consensus Statement by the Androgen Excess and Polycystic Ovary Syndrome (AE-PCOS) Society [DOI]
7. 7 Anti-Müllerian hormone: ovarian reserve testing and its potential clinical implications [DOI]
8. 8 Prevalence and predictors of dyslipidemia in women with polycystic ovary syndrome [DOI]
9. 9 Risk of endometrial, ovarian and breast cancer in women with polycystic ovary syndrome: a systematic review and meta-analysis [DOI]
10. 10 Familial hypercholesterolaemia [DOI]
11. 11 Genetic, hormonal and metabolic aspects of PCOS: an update [DOI]
12. 12 Lipoprotein Lipid Concentrations and Cardiovascular Risk in Women with Polycystic Ovary Syndrome [DOI]
13. 13 Lipid levels in polycystic ovary syndrome: systematic review and meta-analysis [DOI]
14. 14 Diagnosis of Polycystic Ovarian Syndrome: The Rotterdam Criteria Are Premature [DOI]
15. 15 Insulin resistance, polycystic ovary syndrome, and type 2 diabetes mellitus [DOI]
16. 16 Incidence and treatment of metabolic syndrome in newly referred women with confirmed polycystic ovarian syndrome [DOI]
17. 17 PCOS, coronary heart disease, stroke and the influence of obesity: a systematic review and meta-analysis [DOI]
18. 18 Definitions, prevalence and symptoms of polycystic ovaries and polycystic ovary syndrome [DOI]
19. 19 Anxiety and depression in polycystic ovary syndrome: a systematic review and meta-analysis [DOI]
20. 20 Overweight Women with Polycystic Ovary Syndrome Have Evidence of Subclinical Cardiovascular Disease [DOI]
21. 21 Intramuscular testosterone esters and plasma lipids in hypogonadal men: a meta-analysis [DOI]
22. 22 The Role of Genes and Environment in the Etiology of PCOS [DOI]
23. 23 Evolution of Methods for Measurement of HDL-Cholesterol: From Ultracentrifugation to Homogeneous Assays [DOI]
24. 24 Diagnostic Criteria for Polycystic Ovary Syndrome: Pitfalls and Controversies [DOI]
25. 25 Pregnancy Complications in Women with Polycystic Ovary Syndrome [DOI]
26. 26 Chronic testosterone treatment induces selective insulin resistance in subcutaneous adipocytes of women [DOI]
27. 27 Role of Anti-Müllerian Hormone in pathophysiology, diagnosis and treatment of Polycystic Ovary Syndrome: a review [DOI]
28. 28 The Effect of Atorvastatin in Patients with Polycystic Ovary Syndrome: A Randomized Double-Blind Placebo-Controlled Study [DOI]
29. 29 Difference in body weight between American and Italian women with polycystic ovary syndrome: influence of the diet [DOI]
30. 30 Relation of intra-abdominal fat distribution to metabolic disorders in nonobese patients with polycystic ovary syndrome [DOI]
31. 31 Obesity, lipids, cardiovascular risk, and androgen excess [DOI]
32. 32 Atherogenic Lipoprotein Phenotype and Low-Density Lipoproteins Size and Subclasses in Women with Polycystic Ovary Syndrome [DOI]
33. 33 Diagnosis of polycystic ovary syndrome: from NIH criteria to ESHRE-ASRM guidelines.
34. 34 Milder forms of atherogenic dyslipidemia in ovulatory versus anovulatory polycystic ovary syndrome phenotype [DOI]
35. 35 Atherogenic forms of dyslipidaemia in women with polycystic ovary syndrome [DOI]
36. 36 Smaller LDL particle size in women with polycystic ovary syndrome compared to controls [DOI]
37. 37 Medical therapy in women with polycystic ovarian syndrome before and during pregnancy and lactation.
38. 38 Androgens in Polycystic Ovary Syndrome: The Role of Exercise and Diet [DOI]
39. 39 Polycystic ovary syndrome is associated with atherogenic changes in lipoprotein particle number and size independent of body weight [DOI]
40. 40 Assessing Insulin Sensitivity and Resistance in Humans
41. 41 Metabolic Syndrome: Polycystic Ovary Syndrome.
42. 42 Prevalence, Pattern and Predictors for Dyslipidemia of Chinese Women With Polycystic Ovary Syndrome [DOI]
43. 43 Free testosterone, luteinizing hormone/follicle stimulating hormone ratio and pelvic sonography in relation to skin manifestations in patients with polycystic ovary syndrome [DOI]
44. 44 Can serum apolipoprotein C-I demonstrate metabolic abnormality early in women with polycystic ovary syndrome? [DOI]
45. 45 Atherogenic changes in low-density lipoprotein particle profiles were not observed in non-obese women with polycystic ovary syndrome [DOI]
46. 46 LDL Species Heterogeneity in the Atherogenic Dyslipidemia of Polycystic Ovary Syndrome [DOI]
47. 47 … About polycystic ovarian syndrome [DOI]
48. 48 Pharmacotherapy: A Pathophysiologic Approach [DOI]
49. 49 Black's Medical Dictionary [DOI]
50. 50 Can Polycystic Ovarian Syndrome be cured? Unfolding the Concept of Secondary Polycystic Ovarian Syndrome! [DOI]
51. 51 Microglia: sculptors of the polycystic ovary syndrome (PCOS)-like brain? [DOI]

Cited by 14

Showing 4 of 14 known citations — external sources report more than can currently be individually listed.

Related research

• Gender Differences in the Effect of Diabetes Mellitus in Serum Lipid of Diabetics Attending Plateau State Specialist Hospital — shares topic coverage
• Novel Association between Gemfibrozil and Dyslipidemia: A Case Report — shares topic coverage
• Prevalence of Abnormal Lipid Profile Among Obese People in Mogadisho, Somalia — shares topic coverage
• An Observational Case Control Study to Assess the Carotid Intima-media Thickness with Lipid Profile among Type 2 Diabetics — shares topic coverage
• Association between Uterine Fibroid and Metabolic Syndrome in Premenopausal Women — shares topic coverage